EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

05.31.10

Gates Foundation Criticised Again for Monopolising Research

Posted in Bill Gates, Finance, Patents at 3:30 am by Dr. Roy Schestowitz

“The chief of malaria for the World Health Organization has complained that the growing dominance of malaria research by the Bill and Melinda Gates Foundation risks stifling a diversity of views among scientists and wiping out the world health agency’s policy-making function.

New York Times, 2008

Summary: Research diversity is being stifled by the Gates Foundation and Gates-funded ‘studies’ spread misconceptions to defend the foundation’s own agenda

THE Gates Foundation is relevant to this Web site because of the role it plays in promoting Microsoft at the expense of software freedom. Today’s post is more closely related to patents than software and we kindly ask readers to revisit some background in order to understand how the Gates Foundation promotes patents on solutions that save people’s lives. It’s an issue of scarcity where any scarcity means loss of life (patents being the expensive component, not manufacturing).

Thanks to PR efforts from the Gates Foundation (which contracts outside agencies to manage its PR), several high-profile publications continue to promote Gates as a saviour of lives, but the truth (or reality) is a little more complicated than that. Some honourable people do talk about it, but the amount of PR typically marginalises them (by sheer volume).

“Big Pharma gets on board with Gates Foundation,” says this new article which points out:

Although most observers of the Gates Foundation highlight the organization’s influence over grantees, it is clear that the world’s largest philanthropy is exerting a strong influence over the pharmaceutical industry.

As we have shown before, the Gates Foundation is a shareholder and a benefactor in this industry. There actually is a conflict of interests. The Gates Foundation is monopolising research while investing (in the shareholder sense) in the companies that benefit from it. As the Indian press put it some days ago:

Should it be just one big idea, the way Bill and Melinda Gates foundation tackles malaria? (Not even a nano comparison in terms of funding).

The investments are selective and they sometimes come with strings attached. This puts a lot of pressure on researchers to comply with the plan of the Gates Foundation and not anything else. Is this the free thinking that research requires? Does that permit diversity of opinions and breadth of exploration?

Here is another new article:

Although the British drug giant known as GSK was heralded by leading health organizations, the driving force behind the disclosure was the Bill & Melinda Gates Foundation.

For those who do not know or remember, the Head of Global Health for the Gates Foundation is from GlaxoSmithKline where he was caught abusing outside researchers who did not agree with him. Charles Grassley was there in the Senate investigating such inexcusable abuse. GlaxoSmithKline is not the only company which is very much inside the Gates Foundation and we gave more examples before (even Monsanto staff is inside the Gates Foundation).

Anyway, this man is called Tachi Yamada and here he is speaking to the press some days ago.

“Grand Challenges Explorations continues to generate unique and creative ways to tackle global health issues,” said Tachi Yamada, president of the Gates Foundation’s Global Health Programme.

To complete his sentence, they strive to generate unique and creative ways to tackle global health issues by paying big pharmaceutical companies after lobbying governments to allocate funds. That does not mean that the Gates Foundation won’t pay anything; it does pay generously, but it also uses its brand power to further boost investment in companies which it has investments in, using taxpayers' money for the most part. Look who is managing some of these funds:

Arabella Philanthropic Investment Advisors, a philanthropy services firm, is working with ultra-wealthy families’ foundations that are looking to make a philanthropic impact with fewer resources. The firm has done work for The Bill and Melinda Gates Foundation, The Mead Family Foundation and for corporations like Caterpillar and Hyatt.

One might say that taxpayers choose to support Gates’ vision, but not everyone agrees. Gates has just produced a self-serving ‘study’ [1, 2] which is being called “absolute nonsense” by someone who is simply not agreeing with the results of such Gates Foundation-funded research. There is an article about it:

FAIR CEO Blasts Kaiser Foundation & Public Agenda HIV/AIDS Study Results as ‘Absolute Nonsense’

The President and CEO of the FAIR Foundation, Dr. Richard Darling, DDS, is publicly denouncing research studies by the Kaiser Family Foundation and Public Agenda which conclude that Americans want more money spent on HIV/AIDS.

[...]

FAIR points out that in addition to the exorbitant federal funding, The Bill & Melinda Gates Foundation has spent approximately $7 billion on global HIV, TB & malaria efforts and billions of additional dollars have been spent on behalf of HIV patients by the collective efforts of pharmaceutical companies, Hollywood AIDS activists and non-profit organizations such as amfAR (American Federation for AIDS Research).

Let’s not forget the Lancet study from Gates — a ‘study’ which was quite widely disputed [1, 2, 3, 4] but is still appearing in the press.

A new study published in the Lancet and funded by the Gates Foundation, looks at rates of decline, and accelerations and decelerations in rates of decline, in mortality in children younger than 5 years for 187 countries from 1970 to 2009.

There is a quiet fight going on between those who advance the Gates agenda and those who understand that his monopolisation of research (and incestuous relationship with particular companies) is a dangerous one for refinement of drugs. It’s simply irresponsible not to report on these issues, however inconvenient it might be to bring them up.

“Gates has created a huge blood-buying operation that only cares about money, not about people.”

AIDS organisation manager, December 2009 (New York Times)

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

2 Comments

  1. Needs Sunlight said,

    May 31, 2010 at 8:20 am

    Gravatar

    It’s not research, don’t call it that. It’s marketing. Please call it correctly. New Speak can be ignored.

    Dr. Roy Schestowitz Reply:

    To an outside observer it would be “weasel words” (calling research “marketing”). Let’s not preach only to the choir and instead make analysis more widely accessible.

    It is possible to show that research is “marketing” without actually stating this directly.

What Else is New


  1. UPC Roundup: War on the Appeal Boards, British Motion Against the UPC, Fröhlinger Recalled, and Fake News About Spain

    Taking stock of some of the latest attempts to shove the Unitary Patent (UPC) down Europe's throat, courtesy of Team Battistelli and Team UPC



  2. The Sickness of the EPO – Part III: Invalidity and Suicides

    An explanation of what drives a lot of EPO veterans to depression and sometimes even suicide



  3. The Appeal Board (PTAB) and Federal Circuit (CAFC) Maintain Good Pace of Patent Elimination Where Scope Was Exceeded

    The Court of Appeals for the Federal Circuit (CAFC) continues to accept about 4 out of 5 decisions of the Patent Trial and Appeal Board (PTAB) and the US Supreme Court (SCOTUS) refuses to intervene



  4. Software Patents Are Ebbing Away, But the “Swamp” Fights Back and Hijacks the Word “Fix”

    The club of patent maximalists, or those who profit from excess prosecution and legal chaos, isn't liking what has happened in the United States and it wants everything reversed



  5. Report From Yesterday's Debate About the European Patent Office (EPO) at the Bavarian Landtag

    A report of the EPO debate which took place at the Bavarian Landtag yesterday (21/2/2017)



  6. Links 22/2/2017: Wine-Staging 2.2, Nautilus 3.24

    Links for the day



  7. French Politician Richard Yung Tells the Government About Abuses at the European Patent Office (EPO)

    The subject of EPO scandals has once again landed in French politics, just a couple of months since it last happened



  8. The Sickness of the EPO – Part II: Background Information and Insights

    With a privatised, in-house (sometimes outsourced and for-profit) force for surveillance, policing, justice, public relations and now medical assessment (mere vassals or marionettes of the management) the EPO serves to show that it has become indistinguishable from North Korea, where the Supreme Leader gets to control every single aspect (absolutely no separation of powers)



  9. EPO Cartoon/Caricature by KrewinkelKrijst

    A new rendition by Dutch cartoonist and illustrator KrewinkelKrijst



  10. Inverting Narratives: IAM 'Magazine' Paints Massive Patent Bully Microsoft (Preying on the Weak) as a Defender of the Powerless

    Selective coverage and deliberate misinterpretation of Microsoft's tactics (patent settlement under threat, disguised as "pre-installation of some of the US company’s software products") as seen in IAM almost every week these days



  11. The Sickness of the EPO – Part I: Motivation for New Series of Articles

    An introduction or prelude to a long series of upcoming posts, whose purpose is to show governance by coercion, pressure, retribution and tribalism rather than professional relationship between human beings at the European Patent Office (EPO)



  12. Insensitivity at the EPO’s Management – Part VII: EPO Hypocrisy on Cancer and Lack of Feedback to and From ECPC

    The European Cancer Patient Coalition (ECPC), which calls itself "the largest European cancer patients' umbrella organisation," fails to fulfill its duties, says a source of ours, and the EPO makes things even worse



  13. Links 21/2/2017: KDE Plasma 5.9.2 in Chakra GNU/Linux, pfSense 2.3.3

    Links for the day



  14. EPO Caricature: Battistelli's Wall

    Battistelli's solution to everything at the EPO is exclusion and barriers



  15. The 'New' Microsoft is Still Acting Like a Dangerous Cult in an Effort to Hijack and/or Undermine All Free/Open Source Software

    In an effort to combat any large deployment of non-Microsoft software, the company goes personal and attempts to overthrow even management that is not receptive to Microsoft's agenda



  16. PTAB Petitioned to Help Against Patent Troll InfoGation Corp., Which Goes After Linux/Android OEMs in China

    A new example of software patents against Free software, or trolls against companies that are distributing freedom-respecting software from a country where these patents are not even potent (they don't exist there)



  17. Links 20/2/2017: Linux 4.10, LineageOS Milestone

    Links for the day



  18. No, Doing Mathematical Operations on a Processor Does Not Make Algorithms Patent-Eligible

    Old and familiar tricks -- a method for tricking examiners into the idea that algorithms are actual machines -- are being peddled by Watchtroll again



  19. Paid-for UPC Proponent, IAM 'Magazine', Debunked on UPC Again

    The impact of the corrupted (by EPO money) media goes further than one might expect and even 'borrows' out-of-date news in order to promote the UPC



  20. Lack of Justice in and Around the EPO Drawing Scrutiny

    The status of the EPO as an entity above the law (in Germany, the Netherlands, Switzerland and so on) is becoming the subject of press reports and staff is leaving in large numbers



  21. Links 19/2/2017: GParted 0.28.1, LibreOffice Donations Record

    Links for the day



  22. The EPO is Becoming an Embarrassment to Europe and a Growing Threat to the European Union

    The increasingly pathetic moves by Battistelli and the ever-declining image/status of the EPO (only 0% of polled stakeholders approve Battistelli's management) is causing damage to the reputation of the European Union, even if the EPO is not a European Union organ but an international one



  23. Patent Misconceptions Promoted by the Patent Meta-Industry

    Cherry-picking one's way into the perception of patent eligibility for software and the misguided belief that without patents there will be no innovation



  24. As the United States Shuts Its Door on Low-Quality Patents the Patent Trolls Move to Asia

    Disintegration of Intellectual Ventures (further shrinkage after losing software patents at CAFC), China's massive patent bubble, and Singapore's implicit invitation/facilitation of patent trolls (bubble economy)



  25. Links 17/2/2017: Wine 2.2, New Ubuntu LTS

    Links for the day



  26. Bad Advice From Mintz Levin and Bejin Bieneman PLC Would Have People Believe That Software Patents Are Still Worth Pursuing

    The latest examples of misleading articles which, in spite of the avalanche of software patents in the United States, continue to promote these



  27. Patents Are Not Property, They Are a Monopoly, and They Are Not Owned But Temporarily Granted

    Patent maximalism and distortion of concepts associated with patents tackled again, for terminology is being hijacked by those who turned patents into their "milking cows"



  28. SoftBank Group, New Owner of ARM, Could Potentially Become (in Part) a Patent Troll or an Aggressor Like Qualcomm

    SoftBank grabbed headlines (in the West at least) when it bought ARM, but will it soon grab headlines for going after practicing companies using a bunch of patents that it got from Inventergy, ARM, and beyond?



  29. Technicolor, Having Turned Into a Patent Troll, Attacks Android/Tizen/Linux With Patents in Europe

    Technicolor, which a lot of the media portrayed as a patent troll in previous years (especially after it had sued Apple, HTC and Samsung), is now taking action against Samsung in Europe (Paris, Dusseldorf and Mannheim)



  30. Michelle Lee is Still “in Charge” of the US Patent System

    Contrary to a malicious whispering campaign against Lee (a coup attempt, courtesy of patent maximalists who make a living from mass litigation), she is still in charge of the USPTO


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts